Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

The New England Journal of Medicine
H M KeysD Gersell

Abstract

Bulky stage IB cervical cancers have a poorer prognosis than smaller stage I cervical cancers. For the Gynecologic Oncology Group, we conducted a trial to determine whether weekly infusions of cisplatin during radiotherapy improve progression-free and overall survival among patients with bulky stage IB cervical cancer. Women with bulky stage IB cervical cancers (tumor, > or =4 cm in diameter) were randomly assigned to receive radiotherapy alone or in combination with cisplatin (40 mg per square meter of body-surface area once a week for up to six doses; maximal weekly dose, 70 mg), followed in all patients by adjuvant hysterectomy. Women with evidence of lymphadenopathy on computed tomographic scanning or lymphangiography were ineligible unless histologic analysis showed that there was no lymph-node involvement. The cumulative dose of external pelvic and intracavitary radiation was 75 Gy to point A (cervical parametrium) and 55 Gy to point B (pelvic wall). Cisplatin was given during external radiotherapy, and adjuvant hysterectomy was performed three to six weeks later. The relative risks of progression of disease and death among the 183 women assigned to receive radiotherapy and chemotherapy with cisplatin, as compared with th...Continue Reading

References

Jun 1, 1977·Gynecologic Oncology·G D MalkasianE O Jorgensen
Jan 11, 1992·International Journal of Radiation Oncology, Biology, Physics·W W ThomsM J Oswald
Sep 1, 1989·Gynecologic Oncology·C D RunowiczR Byrnes
Mar 1, 1986·Gynecologic Oncology·J A Blessing, B Anderson
Apr 1, 1987·International Journal of Radiation Oncology, Biology, Physics·K E Wallner, G C Li
Aug 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BonomiF J Major
Aug 1, 1969·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·F Y DurranceF N Rutledge
Jul 1, 1981·International Journal of Radiation Oncology, Biology, Physics·P Carde, F Laval
Feb 1, 1980·Gynecologic Oncology·A G O'QuinnJ T Wharton
Dec 31, 1997·Gynecologic Oncology·J H MalfetanoR Ambros
Apr 15, 1999·The New England Journal of Medicine·P G RoseS Insalaco

❮ Previous
Next ❯

Citations

Mar 29, 2001·Journal of Magnetic Resonance Imaging : JMRI·E A BossJ O Barentsz
May 2, 2001·Diseases of the Colon and Rectum·R J PlaceC L Simmang
Sep 28, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Francisco José Andreu-Martínez, Julia M Martínez-Mateu
Feb 17, 2010·Archives of Gynecology and Obstetrics·Na WangTian-Gen Ni
May 25, 2005·Cell and Tissue Research·Murat SonmezerKutluk Oktay
Aug 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christina H RuhlmannJørn Herrstedt
Aug 29, 2006·International Journal of Clinical Oncology·Takafumi Toita
Aug 16, 2008·International Journal of Clinical Oncology·Tsuguhisa NashiroYoichi Aoki
Feb 9, 2012·International Journal of Clinical Oncology·Tetsuo NonakaHiroki Nakayama
Dec 19, 2007·Radiation Medicine·Thumwadee TangsiriwatthanaJeerichuda Pattamadilok
Jun 12, 2002·Current Treatment Options in Oncology·K H Lu, T W Burke
Jun 12, 2002·Current Treatment Options in Oncology·S K Gibbons, H M Keys
Mar 3, 2004·Current Treatment Options in Oncology·Joseph K SalamaArno J Mundt
Mar 3, 2004·Current Treatment Options in Oncology·John O SchorgeJayanthi S Lea
Nov 30, 2000·Current Infectious Disease Reports·M E Hagensee
Dec 21, 2000·Current Oncology Reports·J D Bloss
Oct 3, 2003·Current Oncology Reports·Harry J Long
Oct 16, 2004·Current Oncology Reports·Juan E SardiJuan J Sardi
Oct 14, 2005·Current Oncology Reports·Krishnansu S Tewari, Bradley J Monk
Nov 3, 2010·Current Oncology Reports·Ann H Klopp, Patricia J Eifel
Sep 19, 2012·Current Oncology Reports·Azmat H Sadozye, Nicholas Reed
Dec 21, 2000·Current Oncology Reports·J M Schilder, F B Stehman
Jan 9, 2009·Medical Oncology·Bogdan TorbéRafał Kurzawa
Feb 13, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·V Tormo FerreroR Cardenal Maciá
Jun 18, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Silvia Rodríguez VillalbaJosé Manuel Cervera Grau
Jul 22, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Ana ReigManuel Algara
Feb 4, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Subramanyam DasariLokanatha Valluru
Apr 12, 2005·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C MarchalC Brunaud
Jun 25, 2004·Clinical Oncology : a Journal of the Royal College of Radiologists·L T TanL Burgess
Apr 20, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R RouzierD Castaigne
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Alfonso Dueñas-GonzálezAlejandro Mohar
Jun 1, 2005·International Journal of Radiation Oncology, Biology, Physics·Ji-Hong HongSwei Hsueh
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Nawaid UsmaniWilliam J Mackillop
Feb 14, 2014·International Journal of Radiation Oncology, Biology, Physics·Supriya ChopraShyam Kishore Shrivastava

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.